• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Local and Regional Therapies for Hepatocellular Carcinoma.

作者信息

Kloeckner Roman, Galle Peter Robert, Bruix Jordi

机构信息

Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Department of Internal Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

出版信息

Hepatology. 2021 Jan;73 Suppl 1:137-149. doi: 10.1002/hep.31424. Epub 2020 Nov 6.

DOI:10.1002/hep.31424
PMID:32557715
Abstract
摘要

相似文献

1
Local and Regional Therapies for Hepatocellular Carcinoma.肝细胞癌的局部和区域治疗
Hepatology. 2021 Jan;73 Suppl 1:137-149. doi: 10.1002/hep.31424. Epub 2020 Nov 6.
2
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation.接受肝移植的肝硬化患者肝细胞癌的桥接治疗
Dig Dis Sci. 2008 Oct;53(10):2830-1. doi: 10.1007/s10620-008-0435-3. Epub 2008 Aug 21.
3
What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?肝癌降期治疗的规则应该是什么？
J Gastrointest Cancer. 2020 Dec;51(4):1148-1151. doi: 10.1007/s12029-020-00490-0.
4
Advances in Hepatocellular Carcinoma.肝细胞癌的进展
Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014.
5
Transportal Chemoembolization as Salvage Hepatocellular Carcinoma Therapy to Maintain Liver Transplant Candidacy.经门静脉化疗栓塞术作为挽救性肝细胞癌治疗以维持肝移植候选资格
J Vasc Interv Radiol. 2019 Oct;30(10):1651-1654.e1. doi: 10.1016/j.jvir.2019.03.015. Epub 2019 Jun 4.
6
Effect of Bridging Local-Regional Therapy on Recurrence of Hepatocellular Carcinoma and Survival after Orthotopic Liver Transplantation.桥接局部-区域治疗对肝移植术后肝细胞癌复发和生存的影响。
Radiology. 2017 Mar;282(3):869-879. doi: 10.1148/radiol.2016160288. Epub 2016 Sep 27.
7
Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.等待肝移植期间肝细胞癌的进展
Transplantation. 2015 Sep;99(9):e155-6. doi: 10.1097/TP.0000000000000826.
8
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?局部区域治疗肝癌：过去十年有何变化？
Clin Liver Dis. 2020 Nov;24(4):681-700. doi: 10.1016/j.cld.2020.07.011.
9
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report.腹腔镜下微波热消融治疗肝移植术后局部肝细胞癌晚期复发：病例报告
Prog Transplant. 2014 Jun;24(2):142-5. doi: 10.7182/pit2014632.
10
The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?肝移植降期治疗后的时机选择：等待还是不等待？
J Gastrointest Cancer. 2020 Dec;51(4):1152-1156. doi: 10.1007/s12029-020-00491-z.

引用本文的文献

1
Revisiting the role of local treatments in the era of targeted therapy and immunotherapy for hepatocellular carcinoma.重新审视局部治疗在肝细胞癌靶向治疗和免疫治疗时代的作用。
World J Surg Oncol. 2025 Aug 27;23(1):323. doi: 10.1186/s12957-025-03963-3.
2
A Novel Quadruple Conversion Therapy: Converting Initially Unresectable Hepatocellular Carcinoma to Resectable with pTAE-HAIC, Tyrosine Kinase Inhibitors, and Anti-PD-1 Antibodies.一种新型四联转化疗法：通过肝动脉化疗栓塞术联合肝动脉灌注化疗、酪氨酸激酶抑制剂和抗PD-1抗体将初始不可切除的肝细胞癌转化为可切除。
J Hepatocell Carcinoma. 2025 Aug 14;12:1807-1819. doi: 10.2147/JHC.S523755. eCollection 2025.
3
Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma.
经动脉化疗栓塞术（TACE）、酪氨酸激酶抑制剂（TKIs）和免疫检查点抑制剂（ICIs）用于不可切除的巴塞罗那临床肝癌（BCLC）分期B期和C期肝细胞癌的转化治疗。
Front Immunol. 2025 Jun 10;16:1451965. doi: 10.3389/fimmu.2025.1451965. eCollection 2025.
4
Zinc ions trigger PANoptosis-like cell death in magnetic hyperthermia therapy of magnesium based implant for hepatocellular carcinoma.锌离子在镁基植入物磁热疗治疗肝细胞癌过程中引发类PANoptosis细胞死亡。
Apoptosis. 2025 Jun 19. doi: 10.1007/s10495-025-02132-x.
5
Comprehensive treatment of intermediate and advanced primary hepatocellular carcinoma based on transcatheter arterial chemoembolization (Review).基于经导管动脉化疗栓塞术的中晚期原发性肝细胞癌综合治疗（综述）
Oncol Lett. 2025 May 7;30(1):332. doi: 10.3892/ol.2025.15078. eCollection 2025 Jul.
6
Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS.经颈静脉肝内门体分流术（TIPS）治疗后肝细胞癌（HCC）患者中，肝动脉化疗栓塞术（TACE）联合酪氨酸激酶抑制剂（TKIs）及程序性死亡受体1（PD-1）抑制剂的疗效与安全性
Front Oncol. 2025 Apr 24;15:1570029. doi: 10.3389/fonc.2025.1570029. eCollection 2025.
7
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.经动脉化疗栓塞联合免疫疗法治疗肝细胞癌的协同机制及前景
J Hepatocell Carcinoma. 2025 Apr 30;12:841-854. doi: 10.2147/JHC.S514881. eCollection 2025.
8
Multimodal combination regimen for a patient with advanced huge hepatocellular carcinoma: a case report.晚期巨大肝细胞癌患者的多模式联合治疗方案：一例报告
Transl Gastroenterol Hepatol. 2025 Jan 17;10:17. doi: 10.21037/tgh-24-91. eCollection 2025.
9
Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma.经动脉化疗栓塞的概况代表了肝细胞癌的介入治疗。
World J Gastrointest Surg. 2024 Dec 27;16(12):3903-3906. doi: 10.4240/wjgs.v16.i12.3903.
10
Arginine-Loaded Nano-Calcium-Phosphate-Stabilized Lipiodol Pickering Emulsions Potentiates Transarterial Embolization-Immunotherapy.精氨酸负载的纳米磷酸钙稳定的碘油皮克林乳液增强经动脉栓塞免疫治疗。
Adv Sci (Weinh). 2025 Feb;12(6):e2410484. doi: 10.1002/advs.202410484. Epub 2024 Dec 16.